AtriCure (ATRC)
Your Dashboard
Displaying ATRC Charts
Personalize your Dashboard. You can add and remove charts, drag and drop them into the order you
like, and we'll save your settings for the next time you visit when you're logged in.
Log in here or Click here to register for your free account.
Select or add more charts
- Accounts Payable 5.229M
- Accounts Receivable 9.723M
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization 1.822
- Beneish M-Score Pro
- Beta Pro
- Book Value 14.65M
- Book Value per Share 0.8891
- Capital Expenditures 0.638M
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing 3.438M
- Cash Financing TTM 3.953M
- Cash Investing -0.6972M
- Cash Investing TTM 1.958M
- Cash Operations -1.084M
- Cash Operations TTM -2.198M
- Cash and Equivalents 11.42M
- Cash and ST Investments 15.29M
- Current Ratio 2.802
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio 0.6768
- Dividend
- Dividend Yield 0.00%
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share -0.10
- Earnings Per Share Growth
- Earnings Per Share TTM -0.37
- Earnings Yield -4.12%
- Effective Tax Rate TTM Pro
- Enterprise Value 146.65M
- Expenses 19.10M
- Expenses TTM 72.04M
- Free Cash Flow -1.722M
- Free Cash Flow TTM -3.670M
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin 72.97%
- Gross Profit TTM 47.86M
- Income from Cont. Ops Pro
- Interest Expense 0.2243M
- Interest Income 0.0017M
- Inventories 7.037M
- KZ Index Pro
- Liabilities 21.94M
- Long Term Debt 9.917M
- Market Cap 148.16M
- Net Income -1.620M
- Net Income TTM -5.802M
- Net PP&E 2.544M
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price 8.99
- Price / Book Value 10.11
- Price / Sales Ratio 2.237
- Price / Tangible Book Value Pro
- Profit Margin -9.27%
- R&D Expense 3.389M
- Receivables Turnover 7.008
- Retained Earnings -104.84M
- Retained Earnings Growth
- Return on Assets -16.35%
- Return on Equity -36.58%
- Return on Invested Capital Pro
- Revenue Growth 11.76%
- Revenue Per Share TTM 4.020
- Revenues 17.48M
- Revenues TTM 66.24M
- SG&A Expense 10.86M
- Shareholders Equity 14.65M
- Shares Outstanding 16.48M
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets 36.59M
- Total Return Price 8.99
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
What do these terms mean? Read all about them in the Glossary.
You may also be interested in these ATRC related companies
ATRC News
Listen to $ATRC Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3eG8
about 24 days ago by earningscast
about 24 days ago by earningscast
$ATRC filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Kwl
about 44 days ago by MarketBrief
about 44 days ago by MarketBrief
Leerink Swann Starts AtriCure Inc. (ATRC) at Outperform; Positive Sales Growth Inflection Point
Mar 20, 7:14AM Street Insider
Mar 20, 7:14AM Street Insider
Listen to $ATRC Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2a3D
about 90 days ago by earningscast
about 90 days ago by earningscast
AtriCure to Announce Fourth Quarter and Full Year 2011 Financial Results
Feb 21, 3:00PM Business Wire
Feb 21, 3:00PM Business Wire
Canaccord Genuity Reiterates a 'Buy' on AtriCure (ATRC); ATRC Has Productive STS
Feb 02, 9:36AM Street Insider
Feb 02, 9:36AM Street Insider
$ATRC Ablation System Receives FDA Approval for the Treatment of Atrial Fibrillation
about 163 days ago by Benzinga
about 163 days ago by Benzinga
Listen to $ATRC at piper jaffray health care conference - live at 10:00 AM, ondemand after - http://stks.co/1Jy5
about 179 days ago by earningscast
about 179 days ago by earningscast
$ATRC up 24.2%. Panel Recommends FDA Approval for Atrial Fibrillation Treatment
about 213 days ago by lewisgreen
about 213 days ago by lewisgreen
Great news for cheaper and less invasive treatment from $ATRC : http://on.wsj.com/oMFNyI
about 326 days ago by Mdhemp
about 326 days ago by Mdhemp
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ATRC | 8.99 | +0.58 | +6.90% | 148.16M |
| ATR | 50.61 | -0.45 | -0.88% | 3.366B |
| ATPG | 5.15 | +0.00 | +0.00% | 268.06M |
| ATO | 32.67 | -0.24 | -0.73% | 2.947B |
| ATNI | 32.59 | -0.04 | -0.12% | 503.52M |
| ATML | 7.29 | +0.12 | +1.67% | 3.287B |
| BABY | 11.22 | +0.02 | +0.18% | 330.32M |
| BAB | 29.70 | +0.01 | +0.03% | |
| BAA | 4.37 | +0.16 | +3.80% | 875.27M |
| BA | 70.00 | -1.39 | -1.95% | 52.35B |
